Regulation, innovation and disruption: the European Medicines Agency and adaptive licensing of pharmaceuticals

Growing concerns over the related problems of speedily bringing innovative pharmaceuticals (especially so-called precision medicines) to market, and addressing areas of unmet medical need, have eng...